Peer-influenced content. Sources you trust. No registration required. This is HCN.
Cleveland Clinic Journal of Medicine
Metformin is emerging as a viable option for weight management in obese patients without diabetes, showing sustained weight loss effects and potential benefits in populations with prediabetes or undergoing antipsychotic treatment.
Endocrinology, Diabetes, Metabolism March 13th 2024
Johns Hopkins Medicine
The Johns Hopkins Clozapine Consultation Clinic is addressing the critical underutilization of clozapine in treatment-resistant schizophrenia, providing essential support and education for healthcare providers in navigating its benefits and risks.
Neurology March 12th 2024
Medical Professionals Reference (MPR)
LYN-005 represents a breakthrough in schizophrenia management, showing promise in maintaining therapeutic levels and symptom control with just once-weekly dosing.
Psychiatry February 21st 2024
Psychiatrist.com
The JEWEL study has demonstrated that lurasidone treatment in patients with schizophrenia results in significant improvements in social functioning, with notable progress observed from the early stages of treatment and sustained benefits over a 12-week extension period.
Neurology February 13th 2024
In a phase 3 study, iloperidone demonstrated a significant improvement in treating bipolar mania, marked by a reduction in the Young Mania Rating Scale (YMRS) scores.
Psychiatry February 6th 2024
ReachMD
Explore the latest advances in schizophrenia research and understand how TAAR1 agonism could potentially change the treatment paradigm. Join us in this educational journey.
Psychiatry October 10th 2023